Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02211651 · ClinicalTrials.gov registry record
Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)
A clinical trial, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- 3
- Enrollment target
NCT02211651 is a clinical trial that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 3 participants.
The verdict
NCT02211651 has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to discover the characteristics of pregnant women which increases risk for their babies to develop diabetes, later on in life.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02211651
The ClinicalTrials.gov registry entry for NCT02211651 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02211651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02211651 about?
NCT02211651 is a clinical study titled "Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)". The purpose of this study is to discover the characteristics of pregnant women which increases risk for their babies to develop diabetes, later on in life.
What is the current status of trial NCT02211651?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2013-12. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT02211651?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.